Farzad Nazem
Director · Nautilus Biotechnology, Inc.
Individual
- 2025
- Jun 22, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Farzad Nazem files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AH Equity Partners Bio II, L.L.C. - $11.75M in NAUT purchases and sales in the last 12 months
- Kentaro Suzuki - $6K in NAUT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Farzad Nazem?
Farzad Nazem is a corporate insider, tracked as Director of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Farzad Nazem last file a Form 4?
The most recent primary Form 4 on record is dated 22 June 2026, one of 2 filings going back to 2025.